Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Assessing Risk for Recurrence With the Breast Cancer Index : Episode 3

News

Article

October 1, 2023

Navigating Breast Cancer Treatment Side Effects and Long-Term Care

Author(s):

Kristie L. Kahl

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about side effect management in breast cancer care.

EP: 1.Addressing Scanxiety and Coping with Fear of Breast Cancer Recurrence

EP: 2.Understanding Breast Cancer Recurrence and Treatment Options

Now Viewing

EP: 3.Navigating Breast Cancer Treatment Side Effects and Long-Term Care

EP: 4.Tailoring Breast Cancer Treatment: The Role of Genomic Testing

EP: 5.Genetic and Genomic Testing Unraveled: A Guide for Patients With Breast Cancer

Breast cancer treatment, including the long-term use of anti-estrogen therapy, can bring about various side effects that patients should be aware of, especially since they can play a role in treatment decision-making for some.

As part of its Speaking Out video series, CURE® spoke with Marla Sustin, a nurse practitioner at University Hospitals Seidman Cancer Center in Cleveland, about side effect management and how survivorship care plans can play a role in the long-term care of patients with breast cancer.

For example, aromatase inhibitors may be associated with side effects, such as arthralgia or bone pain, that can be debilitating or affect everyday life.

Patients undergoing tamoxifen treatment should be aware of effects such as an increased risk of endometrial thickening, a potential sign of endometrial cancer; blood clots; and sudden shortness of breath. However, Sustin noted that patients may transition to other medications and treatments, each with its unique set of potential side effects.

In the long term, certain evaluations and tests become essential for monitoring a patient's health. For those on aromatase inhibitors, a baseline bone density scan or DEXA scan is needed, followed by regular monitoring every two to three years. In addition, patients who received cardiotoxic medications during chemotherapy may need to see a specialized cardiologist.

As a result of these side effects, survivorship care plans play a pivotal role in guiding patients through post-treatment life. These plans detail the patient's cancer journey, including tumor grade, stage and treatment specifics, and they provide valuable information about potential side effects and their management to help patients understand their cancer history comprehensively.

Lastly, Sustin suggested that patients can track their side effects effectively by paying close attention to their body and reporting any changes or discomfort to their health care provider. Mental notes or written records of symptoms, their timing, and any possible contributing factors can be helpful to make note of and mention during consultations with providers. Meanwhile, she concluded, engaging with health care providers, nurse navigators or nurse partners can help patients discover available resources to better navigate the challenges of breast cancer treatment and side effects.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Related Content
Advertisement
Image of bonnie.
July 25th 2025

A Valuable Lesson I Learned While Living With Breast Cancer

Bonnie Annis
When I was diagnosed with breast cancer, I never dreamed I’d learn so many valuable life lessons along the way.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of Laura
July 21st 2025

Should I Quit My Day Job While Living With Cancer?

Laura Yeager
Keeping my part-time teaching job during breast cancer treatment gave me purpose, connection and strength — and it helped me rediscover my voice as a writer.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of breast.
July 17th 2025

Enhertu Combo Receives FDA Designation in Metastatic HER2+ Breast Cancer

Ryan Scott
The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer: © stock.adobe.com.
July 15th 2025

Bria-IMT Improves Survival in Patients With Metastatic Breast Cancer

Spencer Feldman
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer.
Related Content
Advertisement
Image of bonnie.
July 25th 2025

A Valuable Lesson I Learned While Living With Breast Cancer

Bonnie Annis
When I was diagnosed with breast cancer, I never dreamed I’d learn so many valuable life lessons along the way.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of Laura
July 21st 2025

Should I Quit My Day Job While Living With Cancer?

Laura Yeager
Keeping my part-time teaching job during breast cancer treatment gave me purpose, connection and strength — and it helped me rediscover my voice as a writer.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of breast.
July 17th 2025

Enhertu Combo Receives FDA Designation in Metastatic HER2+ Breast Cancer

Ryan Scott
The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer: © stock.adobe.com.
July 15th 2025

Bria-IMT Improves Survival in Patients With Metastatic Breast Cancer

Spencer Feldman
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.